Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2018 03:13 ET | Source: Vifor Pharma Ltd.

PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF IV IRON DOSING STRATEGY

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PIVOTAL TRIAL CONFIRMS...
September 20, 2018 00:56 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA ANNOUNCES CHANGES IN MANAGEMENT

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Barbara Angehrn joins Vifor Pharma...
September 18, 2018 01:02 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA GROUP INCREASES EQUITY INVESTMENT IN CHEMOCENTRYX

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Pharma Group increases equity...
August 28, 2018 11:50 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA ISSUES INAUGURAL CHF 465 MILLION BOND

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Pharma today announced the launch of an...
August 08, 2018 02:07 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Strong financial...
August 08, 2018 01:00 ET | Source: Vifor Pharma Ltd.

VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Strong financial performance in...
May 23, 2018 00:59 ET | Source: Vifor Pharma Ltd.

VFMCRP AND CARA THERAPEUTICS TO DEVELOP AND COMMERCIALISE CR845 INJECTION FOR CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Vifor Fresenius Medical Care Renal...
May 15, 2018 12:20 ET | Source: Vifor Pharma Ltd.

90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} All proposals of the Board of...
May 15, 2018 11:34 ET | Source: Vifor Pharma Ltd.

90TH VIFOR PHARMA GROUP ANNUAL SHAREHOLDER MEETING

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} All proposals of the Board of...
May 08, 2018 01:01 ET | Source: Vifor Pharma Ltd.

US FDA APPROVES USE OF VELTASSA® WITH OR WITHOUT FOOD

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Updated label may allow for...